Please login to the form below
PrEP
This page shows the latest PrEP news and features for those working in and with pharma, biotech and healthcare.
MHRA grants approval for AstraZeneca’s Evusheld in the UK
It is the first antibody combination for pre-exposure prophylaxis (PrEP) against COVID-19 to be licensed in the UK.
Latest news
-
EMA launches rolling review of J&J’s COVID-19 vaccine
J&J is also in talks with other global health regulatory authorities as it preps regulatory review processes for the COVID-19 vaccine to be used during the pandemic response period.
-
UK could approve Pfizer’s COVID-19 vaccine this week
The report, which cited government sources, said that British medicines regulators were launching a formal review of the vaccine and added that the NHS has been told to prep itself to
-
UK, China prep trials of coronavirus vaccine candidates
UK vaccine clinical trials set to begin next month
-
NHS England will make PrEP for HIV available in April
Now, they will be able to continue on PrEP after the trial closes. ... NAT also said that the funding commitment only covered one year (2020-2021) raising uncertainty about continued access to PrEP thereafter.
-
IMV preps pivotal trials for ovarian cancer T cell therapy
Drug stabilised disease in 79% of 19 evaluable patients
More from news
Approximately 3 fully matching, plus 39 partially matching documents found.
Latest Intelligence
-
The need for automation in healthcare
After this, from transferring samples into an automatable format through 3D printing hardware, to extraction of RNA from the samples and plate prep for the thermocycling PCR analysis, every subsequent stage
-
Redefining communications excellence
In 2016, Gilead broke its self-enforced moratorium on the marketing of Truvada for PrEP, its drug for preventing HIV. ... A survey run in 2014 and 2015 found two-thirds of primary care physicians had never discussed Truvada for PrEP with their patients.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
14. Both pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) drugs may prevent infection developing. ... PrEP (pre-exposure prophylaxis). Available at: . Accessed November 2018. NHS. Can post-exposure prophylaxis (PEP) stop me getting HIV?
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
